hydralazine has been researched along with Pituitary Neoplasms in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Pituitary Neoplasms: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In contrast, N2 breathing to terminal anoxia and intravenous hydralazine produced a negligible increase in Hb, but large reductions in HbO and HbT." | 1.33 | The effects of tumour blood flow and oxygenation modifiers on subcutaneous tumours as determined by NIRS. ( Connelly, JP; Griffiths, JR; Howe, FA; Robinson, SP; Springett, R, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Howe, FA | 1 |
| Connelly, JP | 1 |
| Robinson, SP | 1 |
| Springett, R | 1 |
| Griffiths, JR | 1 |
1 other study available for hydralazine and Pituitary Neoplasms
| Article | Year |
|---|---|
The effects of tumour blood flow and oxygenation modifiers on subcutaneous tumours as determined by NIRS.
Topics: Animals; Carbon Dioxide; Female; Hemoglobins; Hydralazine; Hyperoxia; Hypoxia; Magnetic Resonance Im | 2005 |